Clinical Trials Browser

Phase 2 × INDUSTRY × Meropenem × Clear all

NCT02732327 2017-07-21

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Phase 2 Terminated

2 enrolled 2 charts

Classical hematology

Neoplasms, Febrile Neutropenia